Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-18 Purchase |
2024-06-21 5:16 pm |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
32,508 | $0.78669 | $25,574 | 186,132 (Direct) |
View |
| 2024-06-13 Purchase |
2024-06-17 6:08 pm |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
36,000 | $0.91373 | $32,894 | 153,624 (Direct) |
View |
| 2024-06-03 Purchase |
2024-06-05 6:12 pm |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
24,000 | $0.77 | $18,480 | 117,624 (Direct) |
View |
| 2024-05-29 Purchase |
2024-05-31 4:56 pm |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
36,000 | $0.6403 | $23,051 | 93,624 (Direct) |
View |
| 2022-11-14 Purchase |
2022-11-16 4:58 pm |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
16,053 | $3.0934 | $49,659 | 24,238 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-03-31 Exercise |
2025-04-02 9:08 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
3,582 | $0 | 91,849 (Direct) |
View |
| 2025-03-31 Tax Withholding |
2025-04-02 9:08 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
744 | $36.41 | 91,849 (Direct) |
View |
| 2025-03-04 Option Award |
2025-03-07 9:09 pm |
N/A 2035-03-04 |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
84,026 | $0 | 95,100 (Direct) |
View |
| 2024-12-31 Tax Withholding |
2025-01-02 6:15 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
721 | $22 | 52,012 (Direct) |
View |
| 2024-12-31 Exercise |
2025-01-02 6:15 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
1,790 | $0 | 52,012 (Direct) |
View |
| 2024-09-30 Tax Withholding |
2024-10-02 7:44 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
535 | $6.74 | 52,733 (Direct) |
View |
| 2024-09-30 Exercise |
2024-10-02 7:44 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
1,791 | $0 | 52,733 (Direct) |
View |
| 2024-06-30 Tax Withholding |
2024-07-02 6:12 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
2,019 | $0.731 | 266,336 (Direct) |
View |
| 2024-06-30 Exercise |
2024-07-02 6:12 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
8,952 | $0 | 266,336 (Direct) |
View |
| 2024-05-22 Option Award |
2024-05-24 4:59 pm |
N/A 2034-05-22 |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
25,000 | $0 | 25,000 (Direct) |
View |
| 2024-03-31 Tax Withholding |
2024-04-02 8:35 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
3,098 | $0.681 | 139,847 (Direct) |
View |
| 2024-03-31 Exercise |
2024-04-02 8:35 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
8,952 | $0 | 139,847 (Direct) |
View |
| 2023-12-31 Tax Withholding |
2024-01-03 7:39 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
3,098 | $0.3402 | 142,945 (Direct) |
View |
| 2023-12-31 Exercise |
2024-01-03 7:39 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
8,952 | $0 | 142,945 (Direct) |
View |
| 2023-09-30 Tax Withholding |
2023-10-03 7:30 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
2,624 | $0.6199 | 146,043 (Direct) |
View |
| 2023-09-30 Exercise |
2023-10-03 7:30 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
8,953 | $0 | 146,043 (Direct) |
View |
| 2023-06-30 Exercise |
2023-07-03 6:51 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
13,841 | $0 | 148,667 (Direct) |
View |
| 2023-06-30 Tax Withholding |
2023-07-03 6:51 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
4,057 | $0.855 | 148,667 (Direct) |
View |
| 2023-03-31 Exercise |
2023-04-04 5:15 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
4,063 | $0 | 74,490 (Direct) |
View |
| 2023-03-31 Tax Withholding |
2023-04-04 5:15 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
1,154 | $1.39 | 74,490 (Direct) |
View |
| 2023-02-01 Option Award |
2023-02-03 6:44 pm |
N/A 2033-02-01 |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
180,922 | $0 | 229,672 (Direct) |
View |
| 2022-12-31 Exercise |
2023-01-03 4:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
4,062 | $0 | 75,644 (Direct) |
View |
| 2022-12-31 Tax Withholding |
2023-01-03 4:07 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
1,406 | $2.37 | 75,644 (Direct) |
View |
| 2022-09-30 Exercise |
2022-10-03 7:42 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
4,063 | $0 | 60,997 (Direct) |
View |
| 2022-09-30 Tax Withholding |
2022-10-03 7:42 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
1,191 | $1.52 | 60,997 (Direct) |
View |
| 2022-06-30 Tax Withholding |
2022-07-01 4:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
2,812 | $2.299 | 62,188 (Direct) |
View |
| 2022-06-30 Exercise |
2022-07-01 4:17 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
8,125 | $0 | 62,188 (Direct) |
View |
| 2022-02-02 Option Award |
2022-02-04 7:29 pm |
N/A 2032-02-01 |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
150,000 | $0 | 150,000 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-02 5:07 pm |
N/A 2031-05-31 |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-02 4:11 pm |
N/A 2031-05-31 |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
70,000 | $0 | 70,000 (Direct) |
View |
Ownership |
2021-06-01 8:04 pm |
N/A N/A |
Monopar Therapeutics | MNPR | Cittadine Andrew Chief Operating Officer |
0 | $0 | 70,000 (Direct) |
View |